Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    "Esophageal varices"
Show Display Options
Rank Status Study
1 Completed “Evaluation of the PillCam™ESO Capsule in the Detection of Esophageal Varices
Condition: Esophageal Varices
Intervention: Device: PillCam Eso
2 Withdrawn Enhancing Detection of Small Esophageal Varices by PillCam ESO
Condition: Esophageal Varices
Interventions: Device: Capsule endoscopy (PillCam ESO);   Procedure: EGD;   Device: Capsule endoscopy (PillCam ESO) with abdominal binder
Interventions: Procedure: ENDOSCOPIC BAND LIGATION;   Drug: PROPRANOLOL;   Device: a multiband ligation device
4 Recruiting Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices
Conditions: Bleeding Esophageal Varices;   Hepatocellular Carcinoma
Interventions: Drug: Propranolol;   Procedure: Esophageal variceal ligation
5 Completed A Prospective Evaluation of Computerized Tomographic(CT) Scanning as a Screening Modality for Esophageal Varices
Conditions: Esophageal Varices;   Portal Hypertension;   Gastric Varices
6 Recruiting Hemodynamic Effects of Terlipressin and High Dose Octreotide
Condition: Gastric and Esophageal Varices
Interventions: Drug: Terlipressin;   Drug: Octreotide
7 Completed Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
Condition: Esophageal Varices
Intervention: Device: Capsule endoscopy, Esophagogastroduodenoscopy
8 Completed Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices
Conditions: Gastrointestinal Bleeding;   Oesophageal Varices
Intervention: Other: Glypressin (terlipressin)
9 Completed Short Course Terlipressin for Control of Acute Variceal Bleeding
Conditions: Hemorrhage;   Esophageal Varices;   Portal Hypertension
Interventions: Drug: Terlipressin;   Drug: Terlipressin & then Dummy
10 Completed A Study of Disposable Transnasal Esophagoscope
Conditions: Gastroesophageal Reflux;   Esophageal Varices;   Esophageal Disease
11 Completed Simvastatin Effect on Portal Hypertension
Conditions: Portal Hypertension;   Esophageal Varices;   Liver Cirrhosis
Interventions: Drug: Simvastatin;   Drug: Placebo pill
12 Terminated Effect of Meal on Portal and Esophagus Variceal Pressure
Conditions: Cirrhosis;   Esophageal Varices
Intervention: Behavioral: meal (food intake)
13 Completed A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices
Condition: Liver Disease
Interventions: Device: Variceal band ligation;   Drug: cyanoacrylate injection
14 Recruiting Self-expandable Esophageal Stent Versus Balloon Tamponade in Refractory Esophageal Variceal Bleeding.
Conditions: Esophageal Varices;   Bleeding;   Cirrhosis
Interventions: Device: Stent;   Device: Tamponade
15 Terminated Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
Condition: Esophageal Varices
Intervention: Procedure: endoscopic variceal band ligation
16 Terminated Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
Conditions: Liver Cirrhosis;   Esophageal Varices
Interventions: Procedure: endoscopic variceal banding;   Drug: propranolol
17 Completed Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
Conditions: Esophageal Varices;   Portal Hypertension;   Gastric Varices;   Esophageal Bleeding
Intervention: Drug: Sanvar®  (vapreotide)
18 Completed EVL (Endoscopic Variceal Ligation) Plus Vasoconstrictor vs.Ligation Plus PPI( Proton Pump Inhibitor) in the Control of Acute Esophageal Variceal Bleeding
Conditions: Esophageal Varices;   Bleeding
Interventions: Drug: pantoloc 40 mg;   Drug: somatostatin or terlipressin
19 Unknown  Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
Conditions: Portal Hypertension Gastropathy;   Esophageal Varices;   Spontaneous Bacterial Peritonitis;   Hepatic Encephalopathy;   Ascites
Interventions: Drug: propranolol;   Drug: carvedilol;   Drug: placebo
20 Completed Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
Conditions: Cirrhosis;   Portal Hypertension;   Esophageal Varices
Interventions: Drug: Long acting octreotide 10mg;   Drug: Long acting Octreotide 30mg;   Drug: Saline

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years